Diagnosing and Managing Migraine: A Patient-Centered Approach
November 1, 2021 at 12pm ET
This is a free, one-hour virtual CME event.
This activity is jointly provided by the Clinical and Patient Educators Association and the Institute for Patient Access. This activity is planned in collaboration with the Clinical Neurological Society of America.
Target Audience
The educational design of this activity addresses the needs of neurologists and primary care providers, including physician assistants and nurse practitioners, who are involved in the direct care of patients with migraine.
Statement of Need/Program Overview
There is an ongoing need for learning activities to educate medical doctors and allied health professionals about the diagnosis and treatment of migraine. This activity will help providers improve their knowledge of new therapeutic options for preventative and abortive treatment options and design an evidence-based management plan for patients with migraine.
Educational Objectives
After completing this activity, learners should be better able to:
- Review best practices for the timely and accurate diagnosis of migraine.
- Identify the mechanisms of action and clinical profiles of new therapeutic options for preventative and abortive treatment of patients with migraine.
- Design patient-centered evidence-based treatment plans for managing migraine.
Faculty
Nada Hindiyeh, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
Stanford Hospital and Clinics
Program Agenda
12-12:05pm: Welcome and introductions
12:05-12:45pm: Lecture covering best practices for diagnosing patients with migraine and designing an evidence-based treatment plan using new therapeutic options for preventative and abortive treatment
12:45-1:00pm: Discussion and audience questions
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Clinical and Patient Educators Association (CPEA) and Institute for Patient Access. CPEA is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
CPEA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPEA Contact Information
For information about the accreditation of this program, please contact CPEA at 303-953-4580 or [email protected].
Instructions for Obtaining Credit
To receive credit, participants must complete the evaluation. Upon completion, participants will be able to download or email their certificate.
System Requirements
This program will be offered via Zoom. Participants must have the ability to view the presentation and ask questions.
Disclosure of Conflicts of Interest
Clinical and Patient Educators Association (CPEA) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by CPEA are required to disclose all financial relationships with any ineligible company within the past 24 months to CPEA. All financial relationships reported are identified as relevant and mitigated by CPEA in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by CPEA to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Name of Faculty or Presenter | Reported Financial Relationship |
Nada Hindiyeh, MD | Consulting Fee: Eli Lilly, Lundbeck, Zosano, Impel |
The planners and managers have the following relevant financial relationships with ineligible companies:
Name of Planner or Manager | Reported Financial Relationship |
Andrea Funk | Nothing to disclose |
Liddy Knight | Nothing to disclose |
Michelle Winokur, DrPH | Nothing to disclose |
Nada Hindiyeh, MD | Consulting Fee: Eli Lilly, Lundbeck, Zosano, Impel |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Clinical and Patient Educators Association (CPEA) and Institute for Patient Access do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
